In vitro activity of double and triple antimicrobial combinations against carbapenem-resistant Pseudomonas aeruginosa biofilm
Journal of Antimicrobial Chemotherapy · 2026
DOI: 10.1093/jac/dkag031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2026. Verfasst von Si-Ho Kim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, South Korea. Hauptthemen laut MEDLINE: Biofilms, Pseudomonas aeruginosa, Anti-Bacterial Agents, Carbapenems. Die Arbeit nennt 44 Literaturangaben. Gefördert von: Future Medicine 2030 Project of the Samsung Medical Center.
Abstract (Originalsprache)
Objectives
Pseudomonas aeruginosa is a common microorganism in chronic infections due to biofilm formation and antibiotic resistance. This study aimed to compare the synergistic effects of antibiotic combinations against carbapenem-resistant P. aeruginosa (CRPA) in planktonic and biofilm-embedded states.
Methods
Twelve CRPA bloodstream isolates from the Asian Bacterial Bank (2016–2018) were analysed. The minimum biofilm eradication concentrations (MBECs) were determined using the peg lid system, and antimicrobial interactions were assessed using biofilm checkerboard assays, testing three double combinations (colistin–rifampin, colistin–imipenem, and rifampin–ceftazidime/avibactam) and two triple combinations (colistin–rifampin–imipenem and colistin–rifampin–ceftazidime/avibactam).
Results
The MBEC values of all four antimicrobial agents (rifampin, colistin, imipenem, and ceftazidime/avibactam) were significantly higher than their corresponding minimum inhibitory concentration values (P < 0.001). Although single agents required markedly elevated concentrations to eradicate CRPA biofilms, approximately half of the double and triple antimicrobial combinations demonstrated synergistic activity. In the biofilm phase, synergism rates were comparable between triple combinations (colistin–rifampin–ceftazidime/avibactam, 50%; colistin–rifampin–imipenem, 66%) and double combinations (colistin–rifampin, 42%; rifampin–ceftazidime/avibactam, 42%; colistin–imipenem, 66%). The triple combinations showed lower FBEC indices (colistin–rifampin–imipenem: median 0.17; colistin–rifampin–ceftazidime/avibactam: 0.34) than the corresponding double combinations (colistin–rifampin: 0.53; colistin–imipenem: 0.20; rifampin–ceftazidime/avibactam: 0.78), although these differences were not statistically significant.
Conclusions
Our study provides experimental evidence that antimicrobial combination therapy may offer advantages over single agents for CRPA biofilm eradication, supporting further investigation into the role of such regimens in biofilm-associated infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, South Korea.
- Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
- Asia Pacific Foundation for Infectious Diseases (APFID), Foundation, Seoul, South Korea.
- Center for Infection Prevention and Control, Samsung Medical Center, Seoul, South Korea.
ORCID-Profile: Si-Ho Kim, Doo Ryeon Chung, Kyungmin Huh
Förderung
- Future Medicine 2030 Project of the Samsung Medical Center
Zitieren
APA
Kim, S. H., Kim, H. M., Chung, D. R., Ko, J. H., Huh, K., Cho, S. Y., Kang, C. I., & Peck, K. R. (2026). In vitro activity of double and triple antimicrobial combinations against carbapenem-resistant Pseudomonas aeruginosa biofilm. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkag031
Vancouver
Kim SH, Kim HM, Chung DR, Ko JH, Huh K, Cho SY, et al. In vitro activity of double and triple antimicrobial combinations against carbapenem-resistant Pseudomonas aeruginosa biofilm. Journal of Antimicrobial Chemotherapy. 2026. doi:10.1093/jac/dkag031
BibTeX
@article{Kim2026,
author = {Kim, Si-Ho and Kim, Hye Mee and Chung, Doo Ryeon and Ko, Jae-Hoon and Huh, Kyungmin and Cho, Sun Young and Kang, Cheol-In and Peck, Kyong Ran},
title = {In vitro activity of double and triple antimicrobial combinations against carbapenem-resistant Pseudomonas aeruginosa biofilm},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2026},
doi = {10.1093/jac/dkag031}
}
EUVIMED